Primary pulmonary hypertension | Clinical Trials Search

找到 50,913 条关于 “Primary pulmonary hypertension”

需要更精确的结果？

可按分期、招募状态、国家、申办方、年龄和研究类型筛选。

高级筛选临床试验

Safety of Terbogrel in Patients With Primary Pulmonary Hypertension

计划入组 33 人 · 首次发布于 2014 年 8 月 22 日

Post-Marketing Surveillance of Ventavis® in Chinese Patients With Primary Pulmonary Hypertension (PPH)

计划入组 38 人 · 首次发布于 2009 年 4 月 17 日

Genetic Research of Bone Morphogenetic Protein Receptor-II Gene in Taiwanese Patient With Primary Pulmonary Hypertension

计划入组 1 人 · 首次发布于 2005 年 9 月 15 日

Safety and Efficacy of Terbogrel in Patients With Primary Pulmonary Hypertension

计划入组 71 人 · 首次发布于 2014 年 8 月 22 日

Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed Ventavis Inhalation Therapy Regarding Safety and Efficacy for up to 4 Years

计划入组 106 人 · 首次发布于 2005 年 11 月 8 日

Genetic and Environmental Characteristics of Primary Pulmonary Hypertension

计划入组 3,000 人 · 首次发布于 2004 年 9 月 13 日

A multicenter, double-blind, randomized, placebo-controlled, parallel group, event-driven, Phase III study to assess the effects of ACT-064992 on morbidity and mortality in patients with symptomatic pulmonary arterial hypertensio

计划入组 7 人

Study Looking at Combination Therapy (Sitaxsentan+Sildenafil) Vs. Monotherapy (Sitaxsentan Alone) SR-PAAS -Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil

计划入组 0 人

An open label clinical trial to study the effects of long term administration of study drug to Improve Clinical Outcome in Pulmonary Arterial Hypertension patients who participated earlier in the Seraphin study

计划入组 4 人

Study Providing Monotherapy (Sitaxsentan) And Combination Therapy (Sitaxsentan+Sildenafil) To Subjects With Pulmonary Arterial Hypertension (PAH) To Assess Long-Term Safety

计划入组 0 人

第 1 页，共 3831 页